Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 5708 entries
Sorted by: Best Match Show Resources per page
Emergency treatment of headache.

Neurology

Rapoport AM, Silberstein SD.
PMID: 1557191
Neurology. 1992 Mar;42(3):43-4.

The first approach in the emergency treatment of headache is the use of abortive measures in an attempt to forestall progression of early signs and symptoms. Abortive measures include analgesics, antiemetics, and anxiolytics; nonsteroidal anti-inflammatory drugs; ergots, generally preceded...

Cite
Rapoport AM, Silberstein SD. Emergency treatment of headache. Neurology. 1992;42(3):43-4
Rapoport, A. M., & Silberstein, S. D. (1992). Emergency treatment of headache. Neurology, 42(3), 43-4.
Rapoport, A M, and Silberstein, S D. "Emergency treatment of headache." Neurology vol. 42,3 (1992): 43-4.
Rapoport AM, Silberstein SD. Emergency treatment of headache. Neurology. 1992 Mar;42(3):43-4. PMID: 1557191.
Copy Download .nbib Format: NLM
Protective effect of Korean Red Ginseng against glucocorticoid-induced osteoporosis in vitro and in vivo.

Journal of ginseng research

Kim J, Lee H, Kang KS, Chun KH, Hwang GS.
PMID: 25535476
J Ginseng Res. 2015 Jan;39(1):46-53. doi: 10.1016/j.jgr.2014.06.001. Epub 2014 Jul 09.

BACKGROUND: Glucocorticoids (GCs) are commonly used in many chemotherapeutic protocols and play an important role in the normal regulation of bone remodeling. However, the prolonged use of GCs results in osteoporosis, which is partially due to apoptosis of osteoblasts...

Cite
Kim J, Lee H, Kang KS, et al. Protective effect of Korean Red Ginseng against glucocorticoid-induced osteoporosis in vitro and in vivo. J Ginseng Res. 2014;39(1):46-53doi: 10.1016/j.jgr.2014.06.001.
Kim, J., Lee, H., Kang, K. S., Chun, K. H., & Hwang, G. S. (2015). Protective effect of Korean Red Ginseng against glucocorticoid-induced osteoporosis in vitro and in vivo. Journal of ginseng research, 39(1), 46-53. https://doi.org/10.1016/j.jgr.2014.06.001
Kim, Jinhee, et al. "Protective effect of Korean Red Ginseng against glucocorticoid-induced osteoporosis in vitro and in vivo." Journal of ginseng research vol. 39,1 (2015): 46-53. doi: https://doi.org/10.1016/j.jgr.2014.06.001
Kim J, Lee H, Kang KS, Chun KH, Hwang GS. Protective effect of Korean Red Ginseng against glucocorticoid-induced osteoporosis in vitro and in vivo. J Ginseng Res. 2015 Jan;39(1):46-53. doi: 10.1016/j.jgr.2014.06.001. Epub 2014 Jul 09. PMID: 25535476; PMCID: PMC4268568.
Copy Download .nbib Format: NLM
Clinical effectiveness analysis of dextran 40 plus dexamethasone on the prevention of fat embolism syndrome.

International journal of clinical and experimental medicine

Liu XM, Huang JC, Wang GD, Lan SH, Wang HS, Pan CW, Zhang JP, Cai XH.
PMID: 25232433
Int J Clin Exp Med. 2014 Aug 15;7(8):2343-6. eCollection 2014.

This study aims to investigate the clinical efficacy of Dextran 40 plus dexamethasone on the prevention of fat embolism syndrome (FES) in high-risk patients with long bone shaft fractures. According to the different preventive medication, a total of 1837...

Cite
Liu XM, Huang JC, Wang GD, et al. Clinical effectiveness analysis of dextran 40 plus dexamethasone on the prevention of fat embolism syndrome. Int J Clin Exp Med. 2014;7(8):2343-6
Liu, X. M., Huang, J. C., Wang, G. D., Lan, S. H., Wang, H. S., Pan, C. W., Zhang, J. P., & Cai, X. H. (2014). Clinical effectiveness analysis of dextran 40 plus dexamethasone on the prevention of fat embolism syndrome. International journal of clinical and experimental medicine, 7(8), 2343-6.
Liu, Xi-Ming, et al. "Clinical effectiveness analysis of dextran 40 plus dexamethasone on the prevention of fat embolism syndrome." International journal of clinical and experimental medicine vol. 7,8 (2014): 2343-6.
Liu XM, Huang JC, Wang GD, Lan SH, Wang HS, Pan CW, Zhang JP, Cai XH. Clinical effectiveness analysis of dextran 40 plus dexamethasone on the prevention of fat embolism syndrome. Int J Clin Exp Med. 2014 Aug 15;7(8):2343-6. eCollection 2014. PMID: 25232433; PMCID: PMC4161593.
Copy Download .nbib Format: NLM
Decreased post-operative pain using a sublingual injection of dexamethasone (8 mg) in lower third molar surgery.

Journal of dental anesthesia and pain medicine

Gozali P, Boonsiriseth K, Kiattavornchareon S, Khanijou M, Wongsirichat N.
PMID: 28879328
J Dent Anesth Pain Med. 2017 Mar;17(1):47-53. doi: 10.17245/jdapm.2017.17.1.47. Epub 2017 Mar 27.

BACKGROUND: Every patient who undergoes mandibular third molar surgery is concerned about post-operative pain. Indeed, previous researchers have used various methods to treat such pain. This study aimed to assess the effectiveness of sublingual injection of dexamethasone (8 mg)...

Cite
Gozali P, Boonsiriseth K, Kiattavornchareon S, et al. Decreased post-operative pain using a sublingual injection of dexamethasone (8 mg) in lower third molar surgery. J Dent Anesth Pain Med. 2017;17(1):47-53doi: 10.17245/jdapm.2017.17.1.47.
Gozali, P., Boonsiriseth, K., Kiattavornchareon, S., Khanijou, M., & Wongsirichat, N. (2017). Decreased post-operative pain using a sublingual injection of dexamethasone (8 mg) in lower third molar surgery. Journal of dental anesthesia and pain medicine, 17(1), 47-53. https://doi.org/10.17245/jdapm.2017.17.1.47
Gozali, Peiter, et al. "Decreased post-operative pain using a sublingual injection of dexamethasone (8 mg) in lower third molar surgery." Journal of dental anesthesia and pain medicine vol. 17,1 (2017): 47-53. doi: https://doi.org/10.17245/jdapm.2017.17.1.47
Gozali P, Boonsiriseth K, Kiattavornchareon S, Khanijou M, Wongsirichat N. Decreased post-operative pain using a sublingual injection of dexamethasone (8 mg) in lower third molar surgery. J Dent Anesth Pain Med. 2017 Mar;17(1):47-53. doi: 10.17245/jdapm.2017.17.1.47. Epub 2017 Mar 27. PMID: 28879328; PMCID: PMC5564136.
Copy Download .nbib Format: NLM
Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats.

Journal of clinical and diagnostic research : JCDR

Nayak IMN, Narendar K, M PA, Jamadar MG, Kumar VH.
PMID: 28892924
J Clin Diagn Res. 2017 Jul;11(7):FC06-FC10. doi: 10.7860/JCDR/2017/28418.10193. Epub 2017 Jul 01.

INTRODUCTION: Insulin Resistance is a major cause of Atherosclerosis (AS) and Non Alcoholic Fatty Liver Disease (NAFLD). These lipid alterations in blood vessels and liver may progress to cardiovascular abnormalities and cirrhosis respectively. Drugs like pioglitazone (PIO) and metformin...

Cite
Nayak IMN, Narendar K, M PA, et al. Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats. J Clin Diagn Res. 2017;11(7):FC06-FC10doi: 10.7860/JCDR/2017/28418.10193.
Nayak, I. M. N., Narendar, K., M, P. A., Jamadar, M. G., & Kumar, V. H. (2017). Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats. Journal of clinical and diagnostic research : JCDR, 11(7), FC06-FC10. https://doi.org/10.7860/JCDR/2017/28418.10193
Nayak, I M Nagendra, et al. "Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats." Journal of clinical and diagnostic research : JCDR vol. 11,7 (2017): FC06-FC10. doi: https://doi.org/10.7860/JCDR/2017/28418.10193
Nayak IMN, Narendar K, M PA, Jamadar MG, Kumar VH. Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats. J Clin Diagn Res. 2017 Jul;11(7):FC06-FC10. doi: 10.7860/JCDR/2017/28418.10193. Epub 2017 Jul 01. PMID: 28892924; PMCID: PMC5583870.
Copy Download .nbib Format: NLM
Gradient Fractionated Separation of Chondrogenically Committed Cells Derived from Human Embryonic Stem Cells.

BioResearch open access

Joergensen NL, Gabrielsen A, Lind M, Lysdahl H.
PMID: 26309787
Biores Open Access. 2015 Jan 01;4(1):109-14. doi: 10.1089/biores.2014.0051. eCollection 2015.

Cartilage regeneration is a fast growing field that combines biotechnology and molecular techniques in creating new tissue mimicking the native microenvironment. Human embryonic stem cells (hESCs) are a highly potent cell source for cartilage regeneration owing to their infinite...

Cite
Joergensen NL, Gabrielsen A, Lind M, et al. Gradient Fractionated Separation of Chondrogenically Committed Cells Derived from Human Embryonic Stem Cells. Biores Open Access. 2015;4(1):109-14doi: 10.1089/biores.2014.0051.
Joergensen, N. L., Gabrielsen, A., Lind, M., & Lysdahl, H. (2015). Gradient Fractionated Separation of Chondrogenically Committed Cells Derived from Human Embryonic Stem Cells. BioResearch open access, 4(1), 109-14. https://doi.org/10.1089/biores.2014.0051
Joergensen, Natasja Leth, et al. "Gradient Fractionated Separation of Chondrogenically Committed Cells Derived from Human Embryonic Stem Cells." BioResearch open access vol. 4,1 (2015): 109-14. doi: https://doi.org/10.1089/biores.2014.0051
Joergensen NL, Gabrielsen A, Lind M, Lysdahl H. Gradient Fractionated Separation of Chondrogenically Committed Cells Derived from Human Embryonic Stem Cells. Biores Open Access. 2015 Jan 01;4(1):109-14. doi: 10.1089/biores.2014.0051. eCollection 2015. PMID: 26309787; PMCID: PMC4497648.
Copy Download .nbib Format: NLM
The Prevalence and Management of Systemic Amyloidosis in Western Countries.

Kidney diseases (Basel, Switzerland)

Nienhuis HL, Bijzet J, Hazenberg BP.
PMID: 27536687
Kidney Dis (Basel). 2016 Apr;2(1):10-9. doi: 10.1159/000444206. Epub 2016 Feb 25.

BACKGROUND: Amyloidosis has been a mystery for centuries, but research of the last decennia has clarified many of the secrets of this group of diseases. A protein-based classification of amyloidosis helps to understand problems that were part of the...

Cite
Nienhuis HL, Bijzet J, Hazenberg BP. The Prevalence and Management of Systemic Amyloidosis in Western Countries. Kidney Dis (Basel). 2016;2(1):10-9doi: 10.1159/000444206.
Nienhuis, H. L., Bijzet, J., & Hazenberg, B. P. (2016). The Prevalence and Management of Systemic Amyloidosis in Western Countries. Kidney diseases (Basel, Switzerland), 2(1), 10-9. https://doi.org/10.1159/000444206
Nienhuis, Hans L A, et al. "The Prevalence and Management of Systemic Amyloidosis in Western Countries." Kidney diseases (Basel, Switzerland) vol. 2,1 (2016): 10-9. doi: https://doi.org/10.1159/000444206
Nienhuis HL, Bijzet J, Hazenberg BP. The Prevalence and Management of Systemic Amyloidosis in Western Countries. Kidney Dis (Basel). 2016 Apr;2(1):10-9. doi: 10.1159/000444206. Epub 2016 Feb 25. PMID: 27536687; PMCID: PMC4946260.
Copy Download .nbib Format: NLM
An Approach to In Vitro Manufacturing of Hypertrophic Cartilage Matrix for Bone Repair.

Bioengineering (Basel, Switzerland)

Quang Le B, Van Blitterswijk C, De Boer J.
PMID: 28952514
Bioengineering (Basel). 2017 Apr 20;4(2). doi: 10.3390/bioengineering4020035.

Devitalized hypertrophic cartilage matrix (DCM) is an attractive concept for an off-the-shelf bone graft substitute. Upon implantation, DCM can trigger the natural endochondral ossification process, but only when the hypertrophic cartilage matrix has been reconstituted correctly. In vivo hypertrophic...

Cite
Quang Le B, Van Blitterswijk C, De Boer J. An Approach to In Vitro Manufacturing of Hypertrophic Cartilage Matrix for Bone Repair. Bioengineering (Basel). 2017;4(2)doi: 10.3390/bioengineering4020035.
Quang Le, B., Van Blitterswijk, C., & De Boer, J. (2017). An Approach to In Vitro Manufacturing of Hypertrophic Cartilage Matrix for Bone Repair. Bioengineering (Basel, Switzerland), 4(2), . https://doi.org/10.3390/bioengineering4020035
Quang Le, Bach, et al. "An Approach to In Vitro Manufacturing of Hypertrophic Cartilage Matrix for Bone Repair." Bioengineering (Basel, Switzerland) vol. 4,2 (2017). doi: https://doi.org/10.3390/bioengineering4020035
Quang Le B, Van Blitterswijk C, De Boer J. An Approach to In Vitro Manufacturing of Hypertrophic Cartilage Matrix for Bone Repair. Bioengineering (Basel). 2017 Apr 20;4(2). doi: 10.3390/bioengineering4020035. PMID: 28952514; PMCID: PMC5590482.
Copy Download .nbib Format: NLM
Atorvastatin-Diltiazem Combination Induced Rhabdomyolysis Leading to Diagnosis of Hypothyroidism.

Case reports in medicine

Ehelepola NDB, Sathkumara SMBY, Bandara HMPAGS, Kalupahana KLR.
PMID: 28487744
Case Rep Med. 2017;2017:8383251. doi: 10.1155/2017/8383251. Epub 2017 Apr 11.

Statins and hypothyroidism, independently, can rarely cause rhabdomyolysis. The combination of them especially with concurrent intake of drugs such as diltiazem increases the risk of rhabdomyolysis. Hashimoto's encephalopathy is a rare condition associated with Hashimoto's thyroiditis and some patients...

Cite
Ehelepola NDB, Sathkumara SMBY, Bandara HMPAGS, et al. Atorvastatin-Diltiazem Combination Induced Rhabdomyolysis Leading to Diagnosis of Hypothyroidism. Case Rep Med. 2017;2017:8383251doi: 10.1155/2017/8383251.
Ehelepola, N. D. B., Sathkumara, S. M. B. Y., Bandara, H. M. P. A. G. S., & Kalupahana, K. L. R. (2017). Atorvastatin-Diltiazem Combination Induced Rhabdomyolysis Leading to Diagnosis of Hypothyroidism. Case reports in medicine, 20178383251. https://doi.org/10.1155/2017/8383251
Ehelepola, N D B, et al. "Atorvastatin-Diltiazem Combination Induced Rhabdomyolysis Leading to Diagnosis of Hypothyroidism." Case reports in medicine vol. 2017 (2017): 8383251. doi: https://doi.org/10.1155/2017/8383251
Ehelepola NDB, Sathkumara SMBY, Bandara HMPAGS, Kalupahana KLR. Atorvastatin-Diltiazem Combination Induced Rhabdomyolysis Leading to Diagnosis of Hypothyroidism. Case Rep Med. 2017;2017:8383251. doi: 10.1155/2017/8383251. Epub 2017 Apr 11. PMID: 28487744; PMCID: PMC5405347.
Copy Download .nbib Format: NLM
Pulmonary Venous Obstruction in Cancer Patients.

Journal of oncology

Liaw CC, Chang H, Yang TS, Wen MS.
PMID: 26425121
J Oncol. 2015;2015:210916. doi: 10.1155/2015/210916. Epub 2015 Sep 06.

Background. We study the clinical significance and management of pulmonary venous obstruction in cancer patients. Methods. We conducted a prospective cohort study to characterize the syndrome that we term "pulmonary vein obstruction syndrome" (PVOS) between January 2005 and March...

Cite
Liaw CC, Chang H, Yang TS, et al. Pulmonary Venous Obstruction in Cancer Patients. J Oncol. 2015;2015:210916doi: 10.1155/2015/210916.
Liaw, C. C., Chang, H., Yang, T. S., & Wen, M. S. (2015). Pulmonary Venous Obstruction in Cancer Patients. Journal of oncology, 2015210916. https://doi.org/10.1155/2015/210916
Liaw, Chuang-Chi, et al. "Pulmonary Venous Obstruction in Cancer Patients." Journal of oncology vol. 2015 (2015): 210916. doi: https://doi.org/10.1155/2015/210916
Liaw CC, Chang H, Yang TS, Wen MS. Pulmonary Venous Obstruction in Cancer Patients. J Oncol. 2015;2015:210916. doi: 10.1155/2015/210916. Epub 2015 Sep 06. PMID: 26425121; PMCID: PMC4575742.
Copy Download .nbib Format: NLM
The prophylactic effect of dexamethasone on postoperative sore throat in prone position surgery.

Korean journal of anesthesiology

Lee SH, Lee YC, Lee JH, Choi SR, Lee SC, Lee JH, Chung CJ.
PMID: 27274371
Korean J Anesthesiol. 2016 Jun;69(3):255-61. doi: 10.4097/kjae.2016.69.3.255. Epub 2016 Jun 01.

BACKGROUND: Sore throat and hoarseness are common complications after general anesthesia with tracheal intubation. The position for patients can affect the incidence of postoperative sore throat (POST) by causing displacement of the endotracheal tube. This study investigated the prophylactic...

Cite
Lee SH, Lee YC, Lee JH, et al. The prophylactic effect of dexamethasone on postoperative sore throat in prone position surgery. Korean J Anesthesiol. 2016;69(3):255-61doi: 10.4097/kjae.2016.69.3.255.
Lee, S. H., Lee, Y. C., Lee, J. H., Choi, S. R., Lee, S. C., Lee, J. H., & Chung, C. J. (2016). The prophylactic effect of dexamethasone on postoperative sore throat in prone position surgery. Korean journal of anesthesiology, 69(3), 255-61. https://doi.org/10.4097/kjae.2016.69.3.255
Lee, Sang Ho, et al. "The prophylactic effect of dexamethasone on postoperative sore throat in prone position surgery." Korean journal of anesthesiology vol. 69,3 (2016): 255-61. doi: https://doi.org/10.4097/kjae.2016.69.3.255
Lee SH, Lee YC, Lee JH, Choi SR, Lee SC, Lee JH, Chung CJ. The prophylactic effect of dexamethasone on postoperative sore throat in prone position surgery. Korean J Anesthesiol. 2016 Jun;69(3):255-61. doi: 10.4097/kjae.2016.69.3.255. Epub 2016 Jun 01. PMID: 27274371; PMCID: PMC4891538.
Copy Download .nbib Format: NLM
Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.

British journal of cancer

Wong ET, Lok E, Gautam S, Swanson KD.
PMID: 26625224
Br J Cancer. 2015 Dec 01;113(11):1642. doi: 10.1038/bjc.2015.404.

No abstract available.

Cite
Wong ET, Lok E, Gautam S, et al. Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma. Br J Cancer. 2015;113(11):1642doi: 10.1038/bjc.2015.404.
Wong, E. T., Lok, E., Gautam, S., & Swanson, K. D. (2015). Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma. British journal of cancer, 113(11), 1642. https://doi.org/10.1038/bjc.2015.404
Wong, E T, et al. "Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma." British journal of cancer vol. 113,11 (2015): 1642. doi: https://doi.org/10.1038/bjc.2015.404
Wong ET, Lok E, Gautam S, Swanson KD. Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma. Br J Cancer. 2015 Dec 01;113(11):1642. doi: 10.1038/bjc.2015.404. PMID: 26625224; PMCID: PMC4705903.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 5708 entries